Ligand Pharmaceuticals offers biotech exposure with reduced risk through its royalty platform. Discover why its valuation now ...

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused ...

(RTTNews) - Ligand Pharmaceuticals Inc. (LGND ... focus will be on speeding up the launch of Pelthos' Zelsuvmi gel with 10.3 percent berdazimer, used to treat molluscum infections in adults ...